Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Sepsis

Free Subscription Articles published in Clin Infect Dis Retrieve available abstracts of 121 articles: HTML format

Single Articles

August 2025
1. RADER A, Ruffin F, Fai C, Barton KD, et al
   A Systematic Review of Health-Related Quality-of-Life Measurement in Patients With Complicated Intraabdominal Infections.
   Clin Infect Dis. 2025;81.
   PubMed     Abstract available
   
   
   July 2025
2. TILANUS AM, Shields RK, Lodise TP, Drusano GL, et al
   Translating Pharmacokinetic-Pharmacodynamic Principles Into Improved Methodology for Clinical Trials That Compare Intermittent With Prolonged Infusion of Beta-Lactam Antibiotics.
   Clin Infect Dis. 2025;80:1275-1280.
   PubMed     Abstract available
   
   
   June 2025
3. GUPTA S, Klompas M, Rhee C
   Reassessing Procalcitonin-Guided Antibiotic Therapy in Critically Ill Patients with Sepsis: Lessons from the ADAPT-Sepsis Trial.
   Clin Infect Dis. 2025 Jun 20:ciaf336. doi: 10.1093.
   PubMed     Abstract available
   
   
   April 2025
4. PATANWALA AE, Nix DE, Hills TE, Erstad BL, et al
   A National Retrospective Cohort Study Comparing the Effects of Cefepime Versus Piperacillin-Tazobactam on the Development of Severe Acute Kidney Injury in Patients With Septic Shock.
   Clin Infect Dis. 2025;80:770-776.
   PubMed     Abstract available
   
   
   
5. SHAPPELL CN, Yu T, Klompas M, Agan AA, et al
   Frequency of Antibiotic Overtreatment and Associated Harms in Patients Presenting With Suspected Sepsis to the Emergency Department: A Retrospective Cohort Study.
   Clin Infect Dis. 2025 Apr 15:ciaf118. doi: 10.1093.
   PubMed     Abstract available
   
   
   
6. KLOMPAS M, Rhee C
   Revising sepsis definitions to better target and tailor sepsis care.
   Clin Infect Dis. 2025 Apr 10:ciaf187. doi: 10.1093.
   PubMed     Abstract available
   
   
   March 2025
7. TALA-IGHIL T, Garcia-Hermoso D, Dalle F, Cassaing S, et al
   Epidemiology and Prognostic Factors Associated With Mold-Positive Blood Cultures: 10-Year Data From a French Prospective Surveillance Program (2012-2022).
   Clin Infect Dis. 2025;80:529-539.
   PubMed     Abstract available
   
   
   
8. PAPADIMITRIOU-OLIVGERIS M, Senn L, Guery B
   Validation of the proposed definition for complicated coagulase negative staphylococcal bacteremia.
   Clin Infect Dis. 2025 Mar 13:ciaf119. doi: 10.1093.
   PubMed     Abstract available
   
   
   February 2025
9. STEFANOVIC A, Alam ME, Matic N, Larnder A, et al
   Increased Severity of Multidrug-Resistant Shigella sonnei Infections in People Experiencing Homelessness.
   Clin Infect Dis. 2025;80:339-346.
   PubMed     Abstract available
   
   
   
10. GARCIA R, Septimus EJ, LeDonne J, Sturm LK, et al
    Prevention of Vascular Access Device-Associated Hospital-Onset Bacteremia and Fungemia: A Review of Emerging Perspectives and Synthesis of Technical Aspects.
    Clin Infect Dis. 2025;80:444-450.
    PubMed     Abstract available
    
    
    
11. SHAH S, Kline EG, Haidar G, Squires KM, et al
    Rates of Resistance to Ceftazidime-Avibactam and Ceftolozane-Tazobactam Among Patients Treated for Multidrug-Resistant Pseudomonas aeruginosa Bacteremia or Pneumonia.
    Clin Infect Dis. 2025;80:24-28.
    PubMed     Abstract available
    
    
    January 2025
12. CUNNINGHAM CA, Ilges D
    Epidemiology and Outcomes of Antibiotic De-escalation in Patients with Suspected Sepsis in US Hospitals.
    Clin Infect Dis. 2025 Jan 17:ciaf022. doi: 10.1093.
    PubMed    
    
    
    
13. KAM KQ, Klompas M, Rhee C
    Challenges and Opportunities in Leveraging Spectrum Scores to Assess Antibiotic De-escalation Practices and Outcomes in Sepsis.
    Clin Infect Dis. 2025 Jan 17:ciaf023. doi: 10.1093.
    PubMed    
    
    
    
14. VENA A, Tiseo G, Falcone M, Bartalucci C, et al
    Impact of Fluconazole Resistance on the Outcomes of Patients With Candida parapsilosis Bloodstream Infections: A Retrospective Multicenter Study.
    Clin Infect Dis. 2025 Jan 15:ciae603. doi: 10.1093.
    PubMed     Abstract available
    
    
    
15. MATELSKI A, Gregoire B, Beste LA, Varley CD, et al
    Analysis of Repeat Hepatitis C Viremia After Sustained Virologic Response in a Large Cohort of U.S. Veterans.
    Clin Infect Dis. 2025 Jan 9:ciaf008. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2024
16. RUFFIEUX Y, Mwansa-Kambafwile J, Metekoua C, Tombe-Nyahuma T, et al
    HIV-1 Viremia and Cancer Risk in 2.8 Million People: the South African HIV Cancer Match Study.
    Clin Infect Dis. 2024 Dec 30:ciae652. doi: 10.1093.
    PubMed     Abstract available
    
    
    
17. STROMDAHL M, Hagman K, Hedman K, Westman A, et al
    Time to Staphylococcus aureus Blood Culture Positivity as a risk marker of Infective Endocarditis: A Retrospective Cohort Study.
    Clin Infect Dis. 2024 Dec 21:ciae628. doi: 10.1093.
    PubMed     Abstract available
    
    
    
18. KAM KQ, Chen T, Kadri SS, Lawandi A, et al
    Epidemiology and Outcomes of Antibiotic De-escalation in Patients with Suspected Sepsis in US Hospitals.
    Clin Infect Dis. 2024 Dec 6:ciae591. doi: 10.1093.
    PubMed     Abstract available
    
    
    
19. KONDO Y, Klompas M, McKenna CS, Pak TR, et al
    Association Between the Sequence of beta-lactam and Vancomycin Administration and Mortality in Patients with Suspected Sepsis.
    Clin Infect Dis. 2024 Dec 5:ciae599. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2024
20. CAWCUTT KA, Kalil AC
    Is Antibiotic De-Escalation Safe and Beneficial to Patients with Sepsis?
    Clin Infect Dis. 2024 Nov 27:ciae592. doi: 10.1093.
    PubMed    
    
    
    
21. STAVROPOULOU E, Monney P, Tzimas G, Ianculescu N, et al
    Predictors of persistent fever among patients with suspected infective endocarditis: think outside the box.
    Clin Infect Dis. 2024 Nov 27:ciae588. doi: 10.1093.
    PubMed     Abstract available
    
    
    
22. JIMENEZ A, Rosa R, Ayoub S, Guran R, et al
    Factors Associated With Poor Clinical and Microbiologic Outcomes in Candida auris Bloodstream Infection: A Multicenter Retrospective Cohort Study.
    Clin Infect Dis. 2024;79:1262-1268.
    PubMed     Abstract available
    
    
    
23. LANZ C, Meier J, Stockle M, Furrer H, et al
    HIV-1 low-level viremia predicts viral failure in participants on antiretroviral therapy in the Swiss HIV Cohort Study.
    Clin Infect Dis. 2024 Nov 21:ciae569. doi: 10.1093.
    PubMed     Abstract available
    
    
    
24. DAVIS JM, Rana A, Sax PE, Bares SH, et al
    Long-Acting Cabotegravir Plus Rilpivirine in People with HIV with Adherence Challenges and Viremia: Current Data and Future Directions.
    Clin Infect Dis. 2024 Nov 12:ciae557. doi: 10.1093.
    PubMed     Abstract available
    
    
    
25. DAILEY MP
    OPAT and Severe Sepsis Mortality.
    Clin Infect Dis. 2024 Nov 7:ciae553. doi: 10.1093.
    PubMed    
    
    
    October 2024
26. ONG SWX, Luo J, Fridman DJ, Lee SM, et al
    Association Between Infectious Diseases Consultation and Mortality in Hospitalized Patients With Gram-negative Bloodstream Infection: A Retrospective Population-wide Cohort Study.
    Clin Infect Dis. 2024;79:855-863.
    PubMed     Abstract available
    
    
    
27. HICKEY MD, Gistand N, Grochowski J, Mayorga-Munoz F, et al
    48-week viral suppression rates in people with HIV starting long-acting CAB/RPV with initial viremia.
    Clin Infect Dis. 2024 Oct 5:ciae500. doi: 10.1093.
    PubMed     Abstract available
    
    
    
28. TAYLOR SP, Palakshappa JA, Chou SH, Gibbs K, et al
    Development of an Electronic Clinical Surveillance Measure for Unnecessary Rapid Antibiotic Administration in Suspected Sepsis.
    Clin Infect Dis. 2024 Oct 3:ciae445. doi: 10.1093.
    PubMed     Abstract available
    
    
    
29. VIRK HS, Biemond JJ, Earny VA, Chowdhury S, et al
    Unraveling Sepsis Epidemiology in a Low- and Middle-Income Intensive Care Setting Reveals the Alarming Burden of Tropical Infections and Antimicrobial Resistance: A Prospective Observational Study (MARS-India).
    Clin Infect Dis. 2024 Oct 1:ciae486. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2024
30. WEN SCH, Harris PNA, Forde B, Permana B, et al
    Characterization of Gram-negative Bloodstream Infections in Hospitalized Australian Children and Their Clinical Outcomes.
    Clin Infect Dis. 2024;79:734-743.
    PubMed     Abstract available
    
    
    
31. GUTIERREZ F, Fernandez-Gonzalez M, Ledesma C, Losada-Echeberria M, et al
    Virological History Predicts Non-sustained Viral Suppression with Long-Acting Cabotegravir and Rilpivirine Therapy, independent of Pharmacokinetic Parameters.
    Clin Infect Dis. 2024 Sep 19:ciae475. doi: 10.1093.
    PubMed     Abstract available
    
    
    
32. MOURAD A, Nwafo N, Skalla L, Holland TL, et al
    Oral versus intravenous antibiotic therapy for Staphylococcus aureus bacteremia or endocarditis: a systematic review and meta-analysis of randomized controlled trials.
    Clin Infect Dis. 2024 Sep 18:ciae476. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2024
33. PERI AM, Chatfield MD, Ling W, Furuya-Kanamori L, et al
    Rapid Diagnostic Tests and Antimicrobial Stewardship Programs for the Management of Bloodstream Infection: What Is Their Relative Contribution to Improving Clinical Outcomes? A Systematic Review and Network Meta-analysis.
    Clin Infect Dis. 2024;79:502-515.
    PubMed     Abstract available
    
    
    
34. DUDOIGNON E, Camelena F, de Tymowski C, Lafaurie M, et al
    Shorter Versus Longer Course of Antibiotic Therapy for Gram-Negative Bacteremia: Time for a Tailored Duration?
    Clin Infect Dis. 2024;79:577-579.
    PubMed    
    
    
    July 2024
35. MAILLARD A, Dortet L, Delory T, Lafaurie M, et al
    Mutation Rate of AmpC beta-Lactamase-Producing Enterobacterales and Treatment in Clinical Practice: A Word of Caution.
    Clin Infect Dis. 2024;79:52-55.
    PubMed     Abstract available
    
    
    
36. TEMKIN E, Solter E, Lugassy C, Chen D, et al
    The Natural History of Carbapenemase-Producing Enterobacterales: Progression From Carriage of Various Carbapenemases to Bloodstream Infection.
    Clin Infect Dis. 2024;79:22-29.
    PubMed     Abstract available
    
    
    
37. GIANNELLA M, Pascale R, Viale P
    Progression From Carriage to Bloodstream Infection and Fatality by Different Enterobacterales Species, Carbapenemases, and Host Settings: Deciphering the Melting Pot.
    Clin Infect Dis. 2024;79:30-32.
    PubMed    
    
    
    
38. NUSSBAUM EZ, Koo S, Kotton CN
    Oral Antibiotics for Treatment of Gram-Negative Bacteremia in Solid Organ Transplant Recipients: A Propensity Score Weighted Retrospective Observational Study.
    Clin Infect Dis. 2024;79:208-214.
    PubMed     Abstract available
    
    
    
39. SORIANO A, Honore PM, Cornely OA, Chayakulkeeree M, et al
    Treatment Outcomes Among Patients With a Positive Candida Culture Close to Randomization Receiving Rezafungin or Caspofungin in the ReSTORE Study.
    Clin Infect Dis. 2024 Jul 10:ciae363. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2024
40. SWETS MC, Bakk Z, Westgeest AC, Berry K, et al
    Clinical sub-phenotypes of Staphylococcus aureus bacteraemia.
    Clin Infect Dis. 2024 Jun 25:ciae338. doi: 10.1093.
    PubMed     Abstract available
    
    
    
41. OLADAPO-SHITTU O, Cosgrove SE, Rock C, Hsu YJ, et al
    Characterizing Patients Presenting on Hospital Admission With Central Line-Associated Bloodstream Infections: A Multicenter Study.
    Clin Infect Dis. 2024;78:1632-1639.
    PubMed     Abstract available
    
    
    
42. ANKRAH PK, Bock A, Ruffin F, Hanson BM, et al
    Persistent Gram-negative Bloodstream Infection Increases the Risk of Recurrent Bloodstream Infection With the Same Species.
    Clin Infect Dis. 2024;78:1458-1461.
    PubMed     Abstract available
    
    
    
43. HARDY M, Harris PNA, Paterson DL, Chatfield MD, et al
    Win Ratio Analyses of Piperacillin-Tazobactam Versus Meropenem for Ceftriaxone-Nonsusceptible Escherichia coli or Klebsiella pneumoniae Bloodstream Infections: Post Hoc Insights From the MERINO Trial.
    Clin Infect Dis. 2024;78:1482-1489.
    PubMed     Abstract available
    
    
    
44. SENCHYNA F, Murugesan K, Rotunno W, Nadimpalli SS, et al
    Sequential Treatment Failure With Aztreonam-Ceftazidime-Avibactam Followed by Cefiderocol Due to Preexisting and Acquired Mechanisms in a New Delhi Metallo-beta-lactamase-Producing Escherichia coli Causing Fatal Bloodstream Infection.
    Clin Infect Dis. 2024;78:1425-1428.
    PubMed     Abstract available
    
    
    
45. MORQUIN D, Lejeune J, Agostini C, Godreuil S, et al
    Time Is of the Essence: Achieving Prompt and Effective Antimicrobial Therapy of Bloodstream Infection With Advanced Hospital Information Systems.
    Clin Infect Dis. 2024;78:1434-1442.
    PubMed     Abstract available
    
    
    
46. SKRIVANKOVA VW, Huwa J, Muula G, Chiwaya GD, et al
    Virologic Failure and Drug Resistance After Programmatic Switching to Dolutegravir-based First-line Antiretroviral Therapy in Malawi and Zambia.
    Clin Infect Dis. 2024 Jun 7:ciae261. doi: 10.1093.
    PubMed     Abstract available
    
    
    
47. TESHOME BF, Park T, Arackal J, Hampton N, et al
    Preventing New Gram-negative Resistance Through Beta-lactam De-escalation in Hospitalized Patients With Sepsis: A Retrospective Cohort Study.
    Clin Infect Dis. 2024 Jun 6:ciae253. doi: 10.1093.
    PubMed     Abstract available
    
    
    
48. FOURRE N, Zimmermann V, Senn L, Monney P, et al
    Evaluation of the HANDOC score and the 2023 ISCVID and ESC Duke clinical criteria for the diagnosis of infective endocarditis among patients with streptococcal bacteremia.
    Clin Infect Dis. 2024 Jun 6:ciae315. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2024
49. ALEXANDRE M, Prague M, Lhomme E, Lelievre JD, et al
    Definition of Virological Endpoints Improving the Design of Human Immunodeficiency Virus (HIV) Cure Strategies Using Analytical Antiretroviral Treatment Interruption.
    Clin Infect Dis. 2024 May 31:ciae235. doi: 10.1093.
    PubMed     Abstract available
    
    
    
50. ANPALAGAN K, Dotel R, MacFadden DR, Smith S, et al
    Does adjunctive clindamycin have a role in Staphylococcus aureus bacteremia? A protocol for the adjunctive treatment domain of the S. aureus Network Adaptive Platform (SNAP) randomized controlled trial.
    Clin Infect Dis. 2024 May 27:ciae289. doi: 10.1093.
    PubMed     Abstract available
    
    
    
51. RUSSELL CD, Berry K, Cooper G, Sim W, et al
    Distinct clinical endpoints of Staphylococcus aureus bacteraemia complicate assessment of outcome.
    Clin Infect Dis. 2024 May 20:ciae281. doi: 10.1093.
    PubMed     Abstract available
    
    
    
52. PINEDA-REYES R, Neil BH, Orndorff J, Williams-Bouyer N, et al
    Clinical presentation, antimicrobial resistance, and treatment outcomes of Aeromonas human infections: A 14-year retrospective study and comparative genomics of two isolates from fatal cases.
    Clin Infect Dis. 2024 May 17:ciae272. doi: 10.1093.
    PubMed     Abstract available
    
    
    
53. HAREZA DA, Cosgrove SE, Simner PJ, Harris AD, et al
    Is Carbapenem Therapy Necessary for the Treatment of Non-CTX-M Extended-Spectrum beta-Lactamase-Producing Enterobacterales Bloodstream Infections?
    Clin Infect Dis. 2024;78:1103-1110.
    PubMed     Abstract available
    
    
    April 2024
54. SUNNERHAGEN T, Rasmussen M
    Lower specificity of the ESC2023 diagnostic criteria for infective endocarditis when spondylodiscitis is regarded as a vascular phenomenon.
    Clin Infect Dis. 2024 Apr 24:ciae223. doi: 10.1093.
    PubMed     Abstract available
    
    
    
55. FIGGATT MC, Rosen DL, Chu VH, Wu LT, et al
    Long-term risk of serious infections and mortality among patients surviving drug use-associated infective endocarditis.
    Clin Infect Dis. 2024 Apr 20:ciae214. doi: 10.1093.
    PubMed     Abstract available
    
    
    
56. QIU J, Zimmet AN, Bell TD, Gadrey S, et al
    Pathophysiological Responses to Bloodstream Infection in Critically Ill Transplant Recipients Compared With Non-Transplant Recipients.
    Clin Infect Dis. 2024;78:1011-1021.
    PubMed     Abstract available
    
    
    
57. MAILLARD A, Micheli G, Lefevre L, Guyonnet C, et al
    Can Chatbot Artificial Intelligence Replace Infectious Diseases Physicians in the Management of Bloodstream Infections? A Prospective Cohort Study.
    Clin Infect Dis. 2024;78:825-832.
    PubMed     Abstract available
    
    
    
58. HENDRIKS MMC, Schweren KSA, Kleij A, Berrevoets MAH, et al
    Low-risk Staphylococcus aureus bacteremia patients do not require routine diagnostic imaging: A multicenter retrospective cohort study.
    Clin Infect Dis. 2024 Apr 5:ciae187. doi: 10.1093.
    PubMed     Abstract available
    
    
    
59. TSCHUMI N, Lukau B, Tlali K, Motaboli L, et al
    Emergence of acquired dolutegravir resistance in treatment-experienced people with HIV in Lesotho.
    Clin Infect Dis. 2024 Apr 3:ciae185. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2024
60. FOURRE N, Zimmermann V, Senn L, Aruanno M, et al
    Predictors of mortality of streptococcal bacteremia and the role of infectious diseases consultation; a retrospective cohort study.
    Clin Infect Dis. 2024 Mar 25:ciae168. doi: 10.1093.
    PubMed     Abstract available
    
    
    
61. FENG X, Qian C, Fan Y, Li J, et al
    Is Short-Course Antibiotic Therapy Suitable for Pseudomonas aeruginosa Bloodstream Infections in Onco-hematology Patients With Febrile Neutropenia? Results of a Multi-institutional Analysis.
    Clin Infect Dis. 2024;78:518-525.
    PubMed     Abstract available
    
    
    
62. SAKOULAS G, Tsou EE, Geriak M, Vasina L, et al
    Contemporary Management of Staphylococcus aureus Bacteremia: Some Additional Considerations for Clinicians.
    Clin Infect Dis. 2024 Mar 20:ciae080. doi: 10.1093.
    PubMed    
    
    
    February 2024
63. TINGSGARD S, Bastrup Israelsen S, Ostergaard C, Benfield T, et al
    Emulating a Target Trial of Shorter Compared to Longer Course of Antibiotic Therapy for Gram-Negative Bacteremia.
    Clin Infect Dis. 2024;78:292-300.
    PubMed     Abstract available
    
    
    
64. PERI AM, O'Callaghan K, Rafiei N, Graves B, et al
    Persistence of Detectable Pathogens by Culture-Independent Systems (T2 Magnetic Resonance) in Patients With Bloodstream Infection: Prognostic Role and Possible Clinical Implications.
    Clin Infect Dis. 2024;78:283-291.
    PubMed     Abstract available
    
    
    
65. LINDBERG H, Berge A, Jovanovic-Stjernqvist M, Hagstrand Aldman M, et al
    Performance of the 2023 Duke-ISCVID diagnostic criteria for infective endocarditis in relation to the modified Duke criteria and to clinical management- reanalysis of retrospective bacteremia cohorts.
    Clin Infect Dis. 2024 Feb 8:ciae040. doi: 10.1093.
    PubMed     Abstract available
    
    
    
66. MCGUIRE E, Collin SM, Brown CS, Saito M, et al
    Community-acquired Staphylococcus aureus bacteraemia among people who inject drugs: a national cohort study in England, 2017-2020.
    Clin Infect Dis. 2024 Feb 5:ciae056. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2024
67. WIDERSTROM M, Mortberg S, Magnusson M, Fjallstrom P, et al
    Treatment Outcome of Severe Respiratory Type B Tularemia Using Fluoroquinolones.
    Clin Infect Dis. 2024;78.
    PubMed     Abstract available
    
    
    
68. FOWLER VG JR, Das AF, Lipka-Diamond J, Ambler JE, et al
    Exebacase in Addition to Standard-of-Care Antibiotics for Staphylococcus aureus Bloodstream Infections and Right-Sided Infective Endocarditis: A Phase 3, Superiority-Design, Placebo-Controlled, Randomized Clinical Trial (DISRUPT).
    Clin Infect Dis. 2024 Jan 31:ciae043. doi: 10.1093.
    PubMed     Abstract available
    
    
    
69. VARLEY CD, Lowy E, Cartwright EJ, Morgan TR, et al
    Success of the US Veterans Health Administration's Hepatitis C Virus Care Continuum in the Direct-acting Antiviral Era.
    Clin Infect Dis. 2024 Jan 27:ciae025. doi: 10.1093.
    PubMed     Abstract available
    
    
    
70. ROACH DJ, Sridhar S, Oliver E, Rao SR, et al
    Clinical and Genomic Characterization of a Cohort of Patients With Klebsiella pneumoniae Bloodstream Infection.
    Clin Infect Dis. 2024;78:31-39.
    PubMed     Abstract available
    
    
    
71. FENG X, Qian C, Fan Y, Li J, et al
    The Necessity of Studying Antibiotic Duration in Acute Leukemia Patients With Pseudomonas aeruginosa Bloodstream Infection: A Response to Terada and Kanno.
    Clin Infect Dis. 2024 Jan 17:ciae013. doi: 10.1093.
    PubMed    
    
    
    
72. VAN GRIENSVEN J, van Henten S, Kibret A, Kassa M, et al
    Chronic high level parasitemia in HIV-infected individuals with or without visceral leishmaniasis in an endemic area in North-West Ethiopia: potential superspreaders?
    Clin Infect Dis. 2024 Jan 9:ciae002. doi: 10.1093.
    PubMed     Abstract available
    
    
    
73. PAPADIMITRIOU-OLIVGERIS M, Monney P, Frank M, Tzimas G, et al
    Evaluation of the 2023 Duke-ISCVID and 2023 Duke-ESC clinical criteria for the diagnosis of infective endocarditis in a multicenter cohort of patients with Staphylococcus aureus bacteremia.
    Clin Infect Dis. 2024 Jan 3:ciae003. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2023
74. VAN DER VAART TW, Prins JM, Goorhuis A, Lemkes BA, et al
    The utility of risk factors to define complicated Staphylococcus aureus bacteremia in a setting with low MRSA prevalence.
    Clin Infect Dis. 2023 Dec 29:ciad784. doi: 10.1093.
    PubMed     Abstract available
    
    
    
75. WESTGEEST AC, Lambregts MMC, Fowler VG Jr
    Reply to Robertson: True Staphylococcus aureus bacteremia.
    Clin Infect Dis. 2023 Dec 7:ciad753. doi: 10.1093.
    PubMed    
    
    
    
76. ROBERTSON P
    A need to consider divergence in definition of Staphylococcus aureus bacteraemia too.
    Clin Infect Dis. 2023 Dec 7:ciad751. doi: 10.1093.
    PubMed    
    
    
    November 2023
77. MINTER DJ, Appa A, Chambers HF, Doernberg SB, et al
    Executive Summary: State-of-The-Art Review: Contemporary Management of Staphylococcus aureus Bacteremia: Controversies in Clinical Practice.
    Clin Infect Dis. 2023;77:1489-1491.
    PubMed    
    
    
    
78. PAPANICOLAOU GA, Avery RK, Cordonnier C, Duarte RF, et al
    Treatment for First Cytomegalovirus Infection Post-Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir with Valganciclovir.
    Clin Infect Dis. 2023 Nov 30:ciad709. doi: 10.1093.
    PubMed     Abstract available
    
    
    
79. ROGERS R, Rice LB
    Executive Summary: State-of-the-Art Review: Persistent Enterococcal Bacteremia.
    Clin Infect Dis. 2023 Nov 29:ciad613. doi: 10.1093.
    PubMed    
    
    
    
80. ROGERS R, Rice LB
    State-of-the-Art Review: Persistent Enterococcal Bacteremia.
    Clin Infect Dis. 2023 Nov 29:ciad612. doi: 10.1093.
    PubMed    
    
    
    
81. SHULDER S, Tamma PD, Fiawoo S, Dzintars K, et al
    Infectious Diseases Consultation Associated With Reduced Mortality in Gram-Negative Bacteremia.
    Clin Infect Dis. 2023;77:1234-1237.
    PubMed     Abstract available
    
    
    
82. MINTER DJ, Appa A, Chambers HF, Doernberg SB, et al
    Contemporary Management of Staphylococcus aureus Bacteremia-Controversies in Clinical Practice.
    Clin Infect Dis. 2023 Nov 10:ciad500. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2023
83. DE KRETSER D, Mora J, Bloomfield M, Campbell A, et al
    Early oral antibiotic switch in Staphylococcus aureus bacteraemia: The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Early Oral Switch Protocol.
    Clin Infect Dis. 2023 Oct 31:ciad666. doi: 10.1093.
    PubMed     Abstract available
    
    
    
84. HAMAD Y, Bell TD, Kadri SS
    Shifting Tides: Is It Time to Embrace Adjunctive Corticosteroids for Community-Acquired Pneumonia?
    Clin Infect Dis. 2023 Oct 25:ciad498. doi: 10.1093.
    PubMed    
    
    
    
85. DOERNBERG SB, Arias CA, Altman DR, Babiker A, et al
    Priorities and Progress in Gram-positive Bacterial Infection Research by the Antibacterial Resistance Leadership Group: A Narrative Review.
    Clin Infect Dis. 2023;77.
    PubMed     Abstract available
    
    
    
86. RHEE C, Strich JR, Chiotos K, Classen DC, et al
    Improving Sepsis Outcomes in the Era of Pay-for-Performance and Electronic Quality Measures: A Joint IDSA/ACEP/PIDS/SHEA/SHM/SIDP Position Paper.
    Clin Infect Dis. 2023 Oct 13:ciad447. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2023
87. KINAMON T, Dagher M, Park L, Ruffin F, et al
    Risk Factors and Outcomes of Hematogenous Vertebral Osteomyelitis in Patients With Staphylococcus aureus Bacteremia.
    Clin Infect Dis. 2023 Sep 25:ciad377. doi: 10.1093.
    PubMed     Abstract available
    
    
    
88. ELEBYARY O, Fine N, Sun C, Saha ST, et al
    A Primed Neutrophil Subset Predicts the Risk of Bloodstream Infections in Allogeneic Hematopoietic Stem-Cell Transplant Patients: A Prospective Study.
    Clin Infect Dis. 2023;77:752-760.
    PubMed     Abstract available
    
    
    
89. FIDALGO B, Morata L, Cardozo C, Del Rio A, et al
    Information Delay of Significant Bloodstream Isolates and Patient Mortality: A Retrospective Analysis of 6225 Adult Patients With Bloodstream Infections.
    Clin Infect Dis. 2023;77:680-686.
    PubMed     Abstract available
    
    
    August 2023
90. LING L, Zhang JZ, Chang LC, Chiu LCS, et al
    Population sepsis incidence, mortality, and trends in Hong Kong between 2009-2018 using clinical and administrative data.
    Clin Infect Dis. 2023 Aug 19:ciad491. doi: 10.1093.
    PubMed     Abstract available
    
    
    
91. SOTO CL, Hsu AJ, Lee JH, Dzintars K, et al
    Identifying Effective Durations of Antibiotic Therapy for the Treatment of Carbapenem-resistant Enterobacterales Bloodstream Infections: A Multicenter Observational Study.
    Clin Infect Dis. 2023 Aug 16:ciad476. doi: 10.1093.
    PubMed     Abstract available
    
    
    
92. DHALIWAL M, Daneman N
    Utility of Differential Time to Positivity in Diagnosing Central Line-Associated Bloodstream Infections: A Systematic Review and Meta-Analysis.
    Clin Infect Dis. 2023;77:428-437.
    PubMed     Abstract available
    
    
    
93. PAK TR, Young J, McKenna CS, Agan A, et al
    Risk of Misleading Conclusions in Observational Studies of Time-to-Antibiotics and Mortality in Suspected Sepsis.
    Clin Infect Dis. 2023 Aug 2:ciad450. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2023
94. BEZERRA CLPAM, Dos Santos EL, Oliveira MS, Dias MBS, et al
    Crude Mortality Associated With the Empirical Use of Polymyxins in Septic Patients in a Setting of High Prevalence of Carbapenem-Resistant Gram-negative Bacteria: Retrospective Analysis of a Cohort.
    Clin Infect Dis. 2023;77.
    PubMed     Abstract available
    
    
    
95. ROBINSON ML, Johnson J, Naik S, Patil S, et al
    Maternal Colonization Versus Nosocomial Transmission as the Source of Drug-Resistant Bloodstream Infection in an Indian Neonatal Intensive Care Unit: A Prospective Cohort Study.
    Clin Infect Dis. 2023;77.
    PubMed     Abstract available
    
    
    
96. LEE TC, McDonald EG, Tong SYC
    Positron Emission Tomography in Staphylococcus aureus Bacteremia: Peeking Under the Covers.
    Clin Infect Dis. 2023;77:16-18.
    PubMed    
    
    
    June 2023
97. DYRHOVDEN R, Eagan TM, Flotten O, Siljan W, et al
    Pleural empyema caused by Streptococcus intermedius and Fusobacterium nucleatum - a distinct entity of pleural infections.
    Clin Infect Dis. 2023 Jun 22:ciad378. doi: 10.1093.
    PubMed     Abstract available
    
    
    
98. ZEGGIL T, Dalton B
    beta-Lactam Therapeutic Drug Monitoring in Critically Ill Patients.
    Clin Infect Dis. 2023;76:2212-2213.
    PubMed    
    
    
    
99. WESTGEEST AC, Buis DTP, Sigaloff KCE, Ruffin F, et al
    Global Differences in the Management of Staphylococcus aureus Bacteremia: No International Standard of Care.
    Clin Infect Dis. 2023 Jun 13:ciad363. doi: 10.1093.
    PubMed     Abstract available
    
    
    
100. MICHELOW IC, Obaro SK
     Unraveling neonatal sepsis: sharper tools needed for unexpected organisms.
     Clin Infect Dis. 2023 Jun 5:ciad338. doi: 10.1093.
     PubMed    
     
     
     
101. ERICSON JE, Burgoine K, Kumbakumba E, Ochora M, et al
     Neonatal Paenibacilliosis: Paenibacillus infection as a Novel Cause of Sepsis in Term Neonates with High Risk of Sequelae in Uganda.
     Clin Infect Dis. 2023 Jun 5:ciad337. doi: 10.1093.
     PubMed     Abstract available
     
     
     May 2023
102. GALLAGHER JC
     Taking on the Fundamental Questions in Infectious Diseases Two-at-a-Time.
     Clin Infect Dis. 2023;76:1613-1614.
     PubMed    
     
     
     
103. CASTANHEIRA M, Mendes RE, Gales AC
     Global Epidemiology and Mechanisms of Resistance of Acinetobacter baumannii-calcoaceticus Complex.
     Clin Infect Dis. 2023;76.
     PubMed     Abstract available
     
     
     April 2023
104. ADELMAN MW, Septimus EJ, Arias CA
     The accuracy of infection diagnoses among patients meeting Sepsis-3 criteria in the emergency department.
     Clin Infect Dis. 2023 Apr 24:ciad240. doi: 10.1093.
     PubMed    
     
     
     
105. ALVAREZ H, Mocroft A, Ryom L, Neesgaard B, et al
     Plasma HIV-1 RNA and CD4+ T-cell counts are determinants of virological non-suppression outcomes with initial integrase inhibitor-based regimens: A prospective RESPOND cohort study.
     Clin Infect Dis. 2023 Apr 13:ciad219. doi: 10.1093.
     PubMed     Abstract available
     
     
     
106. PAI MP, Cojutti PG, Gerussi V, Della Siega P, et al
     Linezolid Population Pharmacokinetics to Improve Dosing in Cardiosurgical Patients: Factoring a New Drug-Drug Interaction Pathway.
     Clin Infect Dis. 2023;76:1173-1179.
     PubMed     Abstract available
     
     
     March 2023
107. FUJII K, Takada T, Kamitani T, Aoki T, et al
     Diagnostic Performance of Physician Gestalt for Bacteremia in Patients in the Process of Being Admitted With Suspected Infection.
     Clin Infect Dis. 2023;76:1074-1079.
     PubMed     Abstract available
     
     
     
108. FRELING S, Wald-Dickler N, Banerjee J, Canamar CP, et al
     Real-world Application of Oral Therapy for Infective Endocarditis: A Multicenter Retrospective, Cohort Study.
     Clin Infect Dis. 2023 Mar 7:ciad119. doi: 10.1093.
     PubMed     Abstract available
     
     
     
109. VAN DER VAART TW, Prins JM, van Werkhoven CH, Ten Doesschate T, et al
     Positive impact of [18F]FDG-PET/CT on mortality in patients with Staphylococcus aureus bacteremia explained by immortal time bias.
     Clin Infect Dis. 2023 Mar 4:ciad112. doi: 10.1093.
     PubMed     Abstract available
     
     
     
110. COLE JC, Jankowski CA, Verdecia JL, Isache CL, et al
     The time for action is now: the impact of timing of infectious disease consultation for Staphylococcus aureus bacteremia.
     Clin Infect Dis. 2023 Mar 3:ciad110. doi: 10.1093.
     PubMed     Abstract available
     
     
     
111. 
     Correction to: Identifying Sepsis From Foodborne Hospitalization: Incidence and Hospitalization Cost by Pathogen.
     Clin Infect Dis. 2023 Mar 1:ciac507. doi: 10.1093.
     PubMed    
     
     
     February 2023
112. FALCONE M, Tiseo G, Carbonara S, Marino A, et al
     Mortality attributable to bloodstream infections caused by different carbapenem-resistant Gram negative bacilli: results from a nationwide study in Italy (ALARICO Network).
     Clin Infect Dis. 2023 Feb 21:ciad100. doi: 10.1093.
     PubMed     Abstract available
     
     
     
113. BARBER BE, Abd-Rahman AN, Webster R, Potter AJ, et al
     Characterizing the blood stage antimalarial activity of tafenoquine in healthy volunteers experimentally infected with Plasmodium falciparum.
     Clin Infect Dis. 2023 Feb 16:ciad075. doi: 10.1093.
     PubMed     Abstract available
     
     
     
114. PHONGKHUN K, Pothikamjorn T, Srisurapanont K, Manothummetha K, et al
     Prevalence of ocular candidiasis and Candida endophthalmitis in patients with candidemia: A systematic review and meta-analysis.
     Clin Infect Dis. 2023 Feb 8:ciad064. doi: 10.1093.
     PubMed     Abstract available
     
     
     January 2023
115. MCATEER J, Lee JH, Cosgrove SE, Dzintars K, et al
     Defining the Optimal Duration of Therapy for Hospitalized Patients with Complicated Urinary Tract Infections and Associated Bacteremia.
     Clin Infect Dis. 2023 Jan 12:ciad009. doi: 10.1093.
     PubMed     Abstract available
     
     
     
116. LEVI LI, Molina JM
     Cytomegalovirus (CMV) viremia in people with Human Immunodeficiency Virus (HIV): should we treat the CMV? Or the HIV? or Both?
     Clin Infect Dis. 2023 Jan 10:ciad011. doi: 10.1093.
     PubMed    
     
     
     
117. BLANC P, Bonnet F, Leleux O, Perrier A, et al
     Severe bacterial non-AIDS infections in persons with HIV: the epidemiology and evolution of antibiotic resistance over an 18-year period (2000-2017) in the ANRS CO3 AquiVih-Nouvelle-Aquitaine cohort.
     Clin Infect Dis. 2023 Jan 4:ciac978. doi: 10.1093.
     PubMed     Abstract available
     
     
     December 2022
118. FUKUDA N, Balikagala B, Ueno T, Anywar DA, et al
     The impact of sequestration on artemisinin-induced parasite clearance in Plasmodium falciparum malaria in Africa.
     Clin Infect Dis. 2022 Dec 15:ciac944. doi: 10.1093.
     PubMed     Abstract available
     
     
     November 2022
119. RUFFIN F, Dagher M, Park LP, Wanda L, et al
     Black and White Patients with Staphylococcus aureus Bacteremia have Similar Outcomes but Different Risk Factors.
     Clin Infect Dis. 2022 Nov 14. pii: 6826998. doi: 10.1093.
     PubMed     Abstract available
     
     
     July 2022
120. GREEN EW, Ndiaye M, Hossain IM, Olatunji YA, et al
     Pneumonia, meningitis, and septicaemia in adults and older children in rural Gambia: eight years of population-based surveillance.
     Clin Infect Dis. 2022 Jul 29. pii: 6651447. doi: 10.1093.
     PubMed     Abstract available
     
     
     June 2022
121. ANDAGALU B, Watson OJ, Onyango I, Opot B, et al
     Malaria Transmission Dynamics in High Transmission Setting of Western Kenya and the Inadequate Treatment Response to Artemether-lumefantrine in an Asymptomatic Population.
     Clin Infect Dis. 2022 Jun 29. pii: 6619621. doi: 10.1093.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Sepsis is free of charge.